Bristol Myers Squibb announced its $14 billion acquisition of Karuna Therapeutics on Friday, sending KRTX stock into the stratosphere.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Bristol Myers Squibb announced its $14 billion acquisition of Karuna Therapeutics on Friday, sending KRTX stock into the stratosphere.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles